Related stories
Sino Biopharmaceutical Jumps After Cancer Drug Deal With Boehringer
Shares of Sino Biopharmaceutical jumped after a cancer drug deal with Boehringer.
M impact | EQUITY | Nov 05, 2026, 02:13 AM UTC
BGSF Q3 revenue falls on lower billable hours
M impact | EQUITY | Nov 05, 2026, 02:13 AM UTC
Liberty Latin America Reports Quarterly Results
M impact | EQUITY | Nov 05, 2026, 02:12 AM UTC
NAB Shares Fall 6.2% as Bad-Debt Charges Nearly Double
NAB shares were down 6.2% to $38.58 at noon, on track for their worst one-day decline since February 2025, after FY26 bad-debt charges nearly doubled year on year and exceeded anal
M impact | EQUITY | Nov 05, 2026, 02:11 AM UTC
HB Solution Wins 15.6 Billion Won Order
M impact | EQUITY | Nov 05, 2026, 02:10 AM UTC
Duk San Neolux Q3 Operating Profit Rises 36.9% Year-on-Year
M impact | EQUITY | Nov 05, 2026, 02:08 AM UTC